MSH2 Antikörper (AA 327-427)
Kurzübersicht für MSH2 Antikörper (AA 327-427) (ABIN7873978)
Target
Alle MSH2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 327-427
-
Verwendungszweck
- MSH2 Antibody
-
Aufreinigung
- Protein G affinity chromatography
-
Immunogen
- A recombinant human partial protein (amino acids 327-427) was used as the immunogen for this MSH2 antibody.
-
Isotyp
- IgG1, kappa
-
-
-
-
Applikationshinweise
- Optimal dilution of the MSH2 antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store the MSH2 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- MSH2 (Mismatch Repair Protein 2 (MSH2))
-
Andere Bezeichnung
- MSH2
-
Hintergrund
- Mutations in DNA mismatch repair genes are associated with hereditary nonpolyposis colorectal cancer (HNPCC). Initially, inherited mutations in the MSH2 and MLH1 homologs of the bacterial DNA mismatch repair genes MutS and MutL were found at high frequency in HNPCC and were shown to be associated with microsatellite instability. The demonstration that 10 to 45 % of pancreatic, gastric, breast, ovarian and small cell lung cancers also display microsatellite instability has been interpreted to suggest that DNA mismatch repair is not restricted to HNPCC tumors but is a common feature in tumor initiation or progression.
-
UniProt
- P43246
-
Pathways
- DNA Reparatur, Production of Molecular Mediator of Immune Response
Target
-